The appearance is white powder, CAS number is 41136-22-5, molecular formula is C13H11N8O4NaS3. Antibacterial activity was demonstrated by inhibiting the synthesis of bacterial cell walls.

Market Analysis and Insights: Global Ceftezole Sodium API Market
The global Ceftezole Sodium API market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Ceftezole Sodium API Scope and Market Size
The global Ceftezole Sodium API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ceftezole Sodium API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %

Segment by Application
Ceftezole Sodium Injection
Other

The Ceftezole Sodium API market is analysed and market size information is provided by regions (countries). Segment by Application, the Ceftezole Sodium API market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Harbin Pharmaceutical Group
Luoxin Pharmaceutical
Sinopharm Weiqida Pharmaceutical
Hebei Hejia Pharmaceutical
JSN Chemicals
SPC Pharm
Dawnrays
Shandong Haibang pharmaceutical
Zhejiang Dongying Pharmaceutical
Aisia Talent Chemical